Gwendolyn Whitney, President, Head of US Business at Amicus Therapeutics, is a leader in US HealthTech. With ~25 years’ experience, she advances novel innovations and scales business growth for life sciences companies. Known for commercial strategy and building inclusive cultures, she drives growth from rare diseases to blockbuster markets.
666 3rd Ave, 6th Floor, New York, NY 10017